(0.27%) 5 145.25 points
(0.14%) 38 495 points
(0.44%) 17 924 points
(-0.88%) $83.11
(-0.10%) $1.921
(0.00%) $2 347.20
(0.06%) $27.55
(2.13%) $941.70
(-0.17%) $0.933
(-0.18%) $11.01
(-0.34%) $0.798
(1.29%) $93.06
@ $6.26
发出时间: 15 Feb 2024 @ 00:00
回报率: -76.52%
上一信号: Feb 14 - 22:30
上一信号:
回报率: -1.57 %
Live Chart Being Loaded With Signals
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases...
Stats | |
---|---|
今日成交量 | 7.99M |
平均成交量 | 9.80M |
市值 | 393.89M |
EPS | $0 ( 2024-02-15 ) |
下一个收益日期 | ( $-0.260 ) 2024-05-07 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -1.210 |
ATR14 | $0.00800 (0.54%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-15 | Ordonez Kathy | Buy | 37 106 | Common Stock |
2024-03-15 | Ordonez Kathy | Buy | 324 515 | Common Stock |
2024-03-15 | Ordonez Kathy | Sell | 324 515 | Stock Option (right to buy) |
2024-03-15 | Ordonez Kathy | Sell | 37 106 | Stock Option (right to buy) |
2024-03-06 | Meline David W | Buy | 40 000 | Common Stock |
INSIDER POWER |
---|
70.23 |
Last 98 transactions |
Buy: 9 423 437 | Sell: 6 701 044 |
音量 相关性
Pacific Biosciences of 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Pacific Biosciences of 相关性 - 货币/商品
Pacific Biosciences of 财务报表
Annual | 2023 |
营收: | $200.52M |
毛利润: | $40.35M (20.12 %) |
EPS: | $-1.210 |
FY | 2023 |
营收: | $200.52M |
毛利润: | $40.35M (20.12 %) |
EPS: | $-1.210 |
FY | 2022 |
营收: | $128.30M |
毛利润: | $49.04M (38.22 %) |
EPS: | $-1.320 |
FY | 2021 |
营收: | $130.51M |
毛利润: | $58.86M (45.10 %) |
EPS: | $-0.890 |
Financial Reports:
No articles found.
Pacific Biosciences of
Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems. The company provides PacBio's Systems, which conduct, monitor, and analyse biochemical sequencing reactions; consumable products, including single molecule real-time (SMRT) cells; and various reagent kits designed for specific workflow, such as template preparation kit to convert DNA into SMRTbell double-stranded DNA library formats, including molecular biology reagents, such as ligase, buffers, and exonucleases. It also offers binding kits, such as modified DNA polymerase used to bind SMRTbell libraries to the polymerase in preparation for sequencing; and sequencing kits comprise reagents required for on-instrument, real-time sequencing, including the phospholinked nucleotides. The company serves research institutions; commercial laboratories; genome centers; public health labs, hospitals and clinical research institutes, contract research organizations, and academic institutions; pharmaceutical companies; and agricultural companies. It markets its products through a direct sales force in North America and Europe, as well as through distribution partners in Asia, Europe, the Middle East, Africa, and Latin America. Pacific Biosciences of California, Inc. has a development and commercialization agreement with Invitae Corporation. The company was formerly known as Nanofluidics, Inc. and changed its name to Pacific Biosciences of California, Inc. in 2005. Pacific Biosciences of California, Inc. was incorporated in 2000 and is headquartered in Menlo Park, California.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。